These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 12407648
21. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients. Böger CA, Götz AK, Krüger B, Hösl M, Schmitz G, Riegger GA, Krämer BK. Eur J Med Res; 2005 Apr 20; 10(4):161-8. PubMed ID: 15946912 [Abstract] [Full Text] [Related]
22. Inflection point of ascending aortic waveform is a predictive factor for all-cause and cardiovascular mortality in patients with chronic renal failure on hemodialysis. Ueda H, Hayashi T, Tsumura K, Yoshimaru K, Nakayama Y, Yoshikawa J. Am J Hypertens; 2004 Dec 20; 17(12 Pt 1):1151-5. PubMed ID: 15607622 [Abstract] [Full Text] [Related]
23. Comparison of survival between diabetic and non-diabetic patients on maintenance hemodialysis: a single-centre experience. Racki S, Zaputović L, Vujicić B, Crncević-Orlić Z, Dvornik S, Mavrić Z. Diabetes Res Clin Pract; 2007 Feb 20; 75(2):169-75. PubMed ID: 16824639 [Abstract] [Full Text] [Related]
25. Treatment of hypertension in chronic kidney disease. Toto RD. Semin Nephrol; 2005 Nov 20; 25(6):435-9. PubMed ID: 16298269 [Abstract] [Full Text] [Related]
26. [Effect of an ambulatory program devoted to chronic renal insufficiency on the reduction of mobidity and hospitalization among patients at the beginning of dialysis treatment]. Malberti F, Ravani P. G Ital Nefrol; 2003 Nov 20; 20(2):127-32. PubMed ID: 12746797 [Abstract] [Full Text] [Related]
27. Angiotensin Converting Enzyme Inhibitor Dialyzability and Outcomes in Older Patients Receiving Hemodialysis. Weir MA, Fleet JL, Dixon SN, Jain AK, Oliver M, Wald R, McIntyre C, Garg AX. Blood Purif; 2015 Nov 20; 40(3):232-42. PubMed ID: 26382240 [Abstract] [Full Text] [Related]
28. Cardiovascular problems on hemodialysis: current deficits and potential improvement. Ritz E, Bommer J. Clin J Am Soc Nephrol; 2009 Dec 20; 4 Suppl 1():S71-8. PubMed ID: 19996009 [Abstract] [Full Text] [Related]
29. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR. Clin Ther; 2007 Sep 20; 29(9):1803-24. PubMed ID: 18035185 [Abstract] [Full Text] [Related]
31. Mortality rate of patients with end stage renal disease on regular hemodialysis: a single center study. Elsharif ME. Saudi J Kidney Dis Transpl; 2011 May 20; 22(3):594-6. PubMed ID: 21566330 [Abstract] [Full Text] [Related]
32. Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. Locatelli F, Carbarns IR, Maschio G, Mann JF, Ponticelli C, Ritz E, Alberti D, Motolese M, Janin G, Zucchelli P. Kidney Int Suppl; 1997 Dec 20; 63():S63-6. PubMed ID: 9407424 [Abstract] [Full Text] [Related]
33. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. Wong CF, McCarthy M, Howse ML, Williams PS. Ren Fail; 2007 Dec 20; 29(6):653-9. PubMed ID: 17763158 [Abstract] [Full Text] [Related]